Pulmonary alveolar proteinosis (PAP) is a heterogenous dis-order of genetic or acquired etiologies. In some cases con-genital PAP is associated with hereditary surfactant protein (SP)-B deficiency. To date, the molecular defect in the ma-jority of patients with PAP has not been identified. In mice, PAP has been generated by targeted deletion of the genes for either the GM-CSF/IL-3/IL-5 receptor common
ABSTRACT: Pulmonary Alveolar Proteinosis (PAP) is a rare syndrome characterized by pulmonary surfact...
Pulmonary alveolar proteinosis (PAP) is characterized by accumulation of a surfactant-like substance...
AbstractHereditary pulmonary alveolar proteinosis (PAP) caused by mutations in CSF2RA or CSF2RB, whi...
Pulmonary alveolar proteinosis (PAP) is a rare syndrome characterized by the accumulation of surfact...
Pulmonary Alveolar Proteinosis (PAP) is a rare entity characterized by the intra-alveolar accumulati...
Pulmonary Alveolar Proteinosis (PAP) is a rare syndrome characterized by pulmonary surfactant accumu...
Pulmonary alveolar proteinosis (PAP) is a respiratory pathology characterized by the accumulation an...
International audiencePulmonary alveolar proteinosis (PAP) is a rare form of chronic interstitial lu...
We identified a 6-year-old girl with pulmonary alveolar proteinosis (PAP), impaired granulocyte-macr...
Pulmonary Alveolar Proteinosis (PAP) is a rare lung disease characterized by excessive accumulation ...
Background Disruption of granulocyte/macrophage colony-stimulating factor (GM-CSF) signalling causes...
Pulmonary alveolar proteinosis is a rare clinical syndrome that was first described in 1958. Subsequ...
Pulmonary alveolar proteinosis (PAP) is a pulmonary disease characterized by disruption of surfactan...
International audiencePAP is an ultra-rare disease in which surfactant components, that impair gas e...
The pathogenesis of acquired pulmonary alveolar proteinosis (PAP), a rare lung disease characterized...
ABSTRACT: Pulmonary Alveolar Proteinosis (PAP) is a rare syndrome characterized by pulmonary surfact...
Pulmonary alveolar proteinosis (PAP) is characterized by accumulation of a surfactant-like substance...
AbstractHereditary pulmonary alveolar proteinosis (PAP) caused by mutations in CSF2RA or CSF2RB, whi...
Pulmonary alveolar proteinosis (PAP) is a rare syndrome characterized by the accumulation of surfact...
Pulmonary Alveolar Proteinosis (PAP) is a rare entity characterized by the intra-alveolar accumulati...
Pulmonary Alveolar Proteinosis (PAP) is a rare syndrome characterized by pulmonary surfactant accumu...
Pulmonary alveolar proteinosis (PAP) is a respiratory pathology characterized by the accumulation an...
International audiencePulmonary alveolar proteinosis (PAP) is a rare form of chronic interstitial lu...
We identified a 6-year-old girl with pulmonary alveolar proteinosis (PAP), impaired granulocyte-macr...
Pulmonary Alveolar Proteinosis (PAP) is a rare lung disease characterized by excessive accumulation ...
Background Disruption of granulocyte/macrophage colony-stimulating factor (GM-CSF) signalling causes...
Pulmonary alveolar proteinosis is a rare clinical syndrome that was first described in 1958. Subsequ...
Pulmonary alveolar proteinosis (PAP) is a pulmonary disease characterized by disruption of surfactan...
International audiencePAP is an ultra-rare disease in which surfactant components, that impair gas e...
The pathogenesis of acquired pulmonary alveolar proteinosis (PAP), a rare lung disease characterized...
ABSTRACT: Pulmonary Alveolar Proteinosis (PAP) is a rare syndrome characterized by pulmonary surfact...
Pulmonary alveolar proteinosis (PAP) is characterized by accumulation of a surfactant-like substance...
AbstractHereditary pulmonary alveolar proteinosis (PAP) caused by mutations in CSF2RA or CSF2RB, whi...